Cerebral Tau PET with <sup>18</sup> F‐APN‐1607 in Alzheimer's disease: a multicenter phase III diagnostic study
<sup>18</sup>F-PM-PBB3 has good specificity and sensitivity in diagnosing AD and is safe and reliable. It may also provide a reliable biomarker for tracking disease progression and cognitive decline in AD.
Authors
- Yiren Fan
- Yuyuan Huang (ORCID: https://orcid.org/0009-0005-3406-4875)
- Mei Cui
- Jin‐Tai Yu
Institutions
- Fudan University (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101593
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00